Key result
NOS1 deficiency in mice increased mortality after myocardial infarction compared with wild-type mice (HR 2.06; P=0.036) and worsened left ventricular fractional shortening.
Why the study?
Does NOS1 deficiency increase mortality and adverse cardiac remodeling after myocardial infarction in a mouse model?
Does NOS1 deficiency increase mortality and adverse cardiac remodeling after myocardial infarction in a mouse model?
NOS1 deficiency increases mortality and adverse cardiac remodeling after myocardial infarction in mice, suggesting a protective role for intact NOS1 activity.
BACKGROUND: Neuronal nitric oxide synthase (NOS1) plays key cardiac physiological roles, regulating excitation-contraction coupling and exerting an antioxidant effect that maintains tissue NO-redox equilibrium. After myocardial infarction (MI), NOS1 translocates from the sarcoplasmic reticulum to the cell membrane, where it inhibits beta-adrenergic contractility, an effect previously predicted to have adverse consequences. Counter to this idea, we tested the hypothesis that NOS1 has a protective effect after MI. METHODS AND RESULTS: We studied mortality, cardiac remodeling, and upregulation of oxidative stress pathways after MI in NOS1-deficient (NOS1(-/-)) and wild-type C57BL6 (WT) mice. Compared with WT, NOS1(-/-) mice had greater mortality (hazard ratio, 2.06; P=0.036), worse left ventricular (LV) fractional shortening (19.7+/-1.5% versus 27.2+/-1.5%, P<0.05), higher LV diastolic diameter (5.5+/-0.2 versus 4.9+/-0.1 mm, P<0.05), greater residual cellular width (14.9+/-0.5 versus 12.8+/-0.5 microm, P<0.01), and equivalent beta-adrenergic hyporesponsiveness despite similar MI size. Superoxide production increased after MI in both NOS1(-/-) and WT animals, although NO increased only in WT. NADPH oxidase (P<0.05) activity increased transiently in both groups after MI, but NOS1(-/-) mice had persistent basal and post-MI elevations in xanthine oxidoreductase activity. CONCLUSIONS: Together these findings support a protective role for intact NOS1 activity in the heart after MI, despite a potential contribution to LV dysfunction through beta-adrenergic hyporesponsiveness. NOS1 deficiency contributes to an imbalance between oxidative stress and tissue NO signaling, providing a plausible mechanism for adverse consequences of NOS1 deficiency in states of myocardial injury.
No takes yet. Share an insight, caveat, or question.
Saraiva et al. (2005) studied Myocardial Infarction. NOS1 deficiency vs. Wild-type C57BL6 (WT) mice was evaluated on mortality (HR 2.06, p=0.036). NOS1 deficiency in mice increased mortality after myocardial infarction compared with wild-type mice (HR 2.06; P=0.036) and worsened left ventricular fractional shortening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: